<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14830">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01735708</url>
  </required_header>
  <id_info>
    <org_study_id>NR13438</org_study_id>
    <secondary_id>R21NR013438</secondary_id>
    <nct_id>NCT01735708</nct_id>
  </id_info>
  <brief_title>Treating Chronic Pain and Depression in HIV+ Patients in Primary Care Settings</brief_title>
  <acronym>HIVPASS</acronym>
  <official_title>Treating Chronic Pain and Depression in HIV+ Patients in Primary Care Settings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Butler Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Nursing Research (NINR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Butler Hospital</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether participation in the study intervention,
      which involves collaboration between the study interventionist and the participant's primary
      care physician, will reduce symptoms of pain and depression in HIV+ patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>pain interference</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>pain interference will be measured by self-report on the Brief Pain Inventory-Pain Interference Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>depression</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>depression will be measured by self-report on the Quick Inventory of Depression Symptomatology scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>antiretroviral adherence</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>antiretroviral adherence will be measured by self-report on the AIDS Clinical Trial Group adherence measure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain Interference</condition>
  <condition>Depression</condition>
  <condition>Antiretroviral Adherence</condition>
  <arm_group>
    <arm_group_label>Health Education</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants in the Health Education arm will receive 7 individual sessions, each of which will focus on a different health education topic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIVPASS Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in the HIVPASS intervention arm will receive 7 individual sessions with the study interventionist, the first of which is a collaborative meeting with the PCP.  Sessions will focus on pain interference and depression management.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HIVPASS</intervention_name>
    <arm_group_label>HIVPASS Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic Pain (pain duration for at least six months with a mean score of 5 or higher
             on the BPI Pain Interference Scale)

          -  Pain severity of 40 or higher on a Visual Analog Scale (0-100) indicating &quot;worst pain
             in the last week&quot;

          -  At least one trial of PCP-recommended medication (i.e. acetominophen, NSAIDS,
             skeletal muscle relaxants) judged through interviews with patients and PCPs

          -  QIDS score of â‰¥ 9 (depression severity)

          -  Stable dose of an antidepressant, if using, for the previous 2 months

          -  Age 18 or older

          -  HIV+

        Exclusion Criteria:

          -  Lifetime DSM-IV diagnosis of bipolar disorder, schizophrenia, or other chronic
             psychotic condition

          -  Current DSM-IV diagnosis of substance dependence for alcohol, sedative/ hypnotic
             drugs, stimulants, or cocaine

          -  Suicidal ideation or behavior requiring immediate attention

          -  In psychotherapy or in a multidisciplinary pain management program

          -  Expected surgery in the next 6 months

          -  Pain thought to be due to cancer, infection, or inflammatory arthritis

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Stein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Butler Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Stein, MD</last_name>
    <phone>401-445-6646</phone>
    <email>michael_stein@brown.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Butler Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Michael Stein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 8, 2013</lastchanged_date>
  <firstreceived_date>November 26, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Butler Hospital</investigator_affiliation>
    <investigator_full_name>Michael Stein, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>pain</keyword>
  <keyword>depression</keyword>
  <keyword>HIV</keyword>
  <keyword>adherence</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
